As detailed in other articles in the Genomic Medicine series,genomics has contributed greatly to our understanding of themolecular basis of disease and, to a lesser but growing extent,to the development of effective interventions. Clinicians andsociety at large, however, are concerned about the effect geneticknowledge will have on the well-being of individual personsand groups. Much effort is being devoted to trying to anticipate,understand, and address the ethical, legal, social, and politicalimplications of genetics and genomics.
The inquiry is complex. Understanding the social effects ofgenomics requires an analysis of the ways in which . . . [Full Text of this Article]
What Genetic Information Is and What People Are Worried About
The Problem of Discrimination
The Challenge of Genomic Medicine with Respect to the Physician–Patient Relationship
Genomic Medicine and Public Health
Conclusions
Source Information
From the Center for Genetics and Health Policy, Vanderbilt University, Nashville.
Address reprint requests to Dr. Clayton at Vanderbilt University, 507A Light Hall, Nashville, TN 37232-0165.
Related Letters:
Ethics and Genetics
Cunningham G., Deftos L. J., Nowlan W. J., Clayton E. W.
Extract |
Full Text |
PDF
N Engl J Med 2003;
349:1870-1872, Nov 6, 2003.
Correspondence
This article has been cited by other articles:
Federoff, H. J., Gostin, L. O.
(2009). Evolving From Reductionism to Holism: Is There a Future for Systems Medicine?. JAMA
302: 994-996
[Full Text]
Ameer, B., Krivoy, N.
(2009). Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology. J Clin Pharmacol
49: 886-888
[Full Text]
BOGAARD, K., JOHNSON, M.
(2009). Genetics and Genomic Medicine. radtech
80: 318-335
[Abstract][Full Text]
Ormond, K. E.
(2008). Medical Ethics for the Genome World: A Paper from the 2007 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn.
10: 377-382
[Abstract][Full Text]
Cappelen, A W, Norheim, O F, Tungodden, B
(2008). Genomics and equal opportunity ethics. J. Med. Ethics
34: 361-364
[Abstract][Full Text]
Merlo, D F, Knudsen, L E, Matusiewicz, K, Niebroj, L, Vahakangas, K H
(2007). Ethics in studies on children and environmental health. J. Med. Ethics
33: 408-413
[Abstract][Full Text]
Tyler, C. V. Jr., Snyder, C. W.
(2006). Cancer Risk Assessment: Examining the Family Physician's Role. J Am Board Fam Med
19: 468-477
[Abstract][Full Text]
Knoppers, B. M., Chadwick, R.
(2006). Human Genetic Research: Emerging Trends in Ethics. Focus
4: 416-
[Abstract][Full Text]
Weinshilboum, R., Wang, L.
(2006). Pharmacogenomics: Bench to Bedside. Focus
4: 431-
[Abstract][Full Text]
Seo, D., Ginsburg, G. S., Goldschmidt-Clermont, P. J.
(2006). Gene Expression Analysis of Cardiovascular Diseases: Novel Insights Into Biology and Clinical Applications. J Am Coll Cardiol
48: 227-235
[Abstract][Full Text]
Foster, M. W., Sharp, R. R.
(2006). Ethical issues in medical-sequencing research: implications of genotype-phenotype studies for individuals and populations.. Hum Mol Genet
15: R45-R49
[Abstract][Full Text]
Woodhouse, L. D., Auld, M. E., Livingood, W. C., Mulligan, L. A.
(2006). Survey of Accredited Master of Public Health (MPH) Programs With Health Education Concentrations: A Resource for Strengthening the Public Health Workforce. Health Promot Pract
7: 258-265
[Abstract]
Pestka, E. L.
(2005). Genetic Counseling for Mental Health Disorders. J Am Psychiatr Nurses Assoc
11: 338-343
[Abstract]
Thomas, J. C., Irwin, D. E., Zuiker, E. S., Millikan, R. C.
(2005). Genomics and the Public Health Code of Ethics. AJPH
95: 2139-2143
[Abstract][Full Text]
Bailey, D. B. Jr, Skinner, D., Warren, S. F.
(2005). Newborn Screening for Developmental Disabilities: Reframing Presumptive Benefit. AJPH
95: 1889-1893
[Abstract][Full Text]
Mapp, C. E., Boschetto, P., Maestrelli, P., Fabbri, L. M.
(2005). Occupational Asthma. Am. J. Respir. Crit. Care Med.
172: 280-305
[Abstract][Full Text]
Turner, S. S.
(2005). Critical Junctures in Genetic Medicine: The Transformation of DNA Lab Science to Commercial Pharmacogenomics. Journal of Business and Technical Communication
19: 328-352
[Abstract]
Gollust, S. E., Apse, K., Fuller, B. P., Miller, P. S., Biesecker, B. B.
(2005). Community Involvement in Developing Policies for Genetic Testing: Assessing the Interests and Experiences of Individuals Affected by Genetic Conditions. AJPH
95: 35-41
[Abstract][Full Text]
Hunt, C E
(2005). Gene-environment interactions: implications for sudden unexpected deaths in infancy. Arch. Dis. Child.
90: 48-53
[Abstract][Full Text]
Ensenauer, R. E., Michels, V. V., Reinke, S. S.
(2005). Genetic Testing: Practical, Ethical, and Counseling Considerations. Mayo Clin Proc.
80: 63-73
[Abstract]
Offit, K., Groeger, E., Turner, S., Wadsworth, E. A., Weiser, M. A.
(2004). The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks. JAMA
292: 1469-1473
[Abstract][Full Text]
Hamvas, A., Madden, K. K., Nogee, L. M., Trusgnich, M. A., Wegner, D. J., Heins, H. B., Cole, F. S.
(2004). Informed Consent for Genetic Research. Arch Pediatr Adolesc Med
158: 551-555
[Abstract][Full Text]
Hook, C. C., DiMagno, E. P., Tefferi, A.
(2004). Primer on Medical Genomics Part XIII: Ethical and Regulatory Issues. Mayo Clin Proc.
79: 645-650
[Abstract]
Vahakangas, K.
(2004). Ethical aspects of molecular epidemiology of cancer. Carcinogenesis
25: 465-471
[Abstract][Full Text]
Roden, D. M.
(2003). Cardiovascular Pharmacogenomics. Circulation
108: 3071-3074
[Full Text]
Cunningham, G., Deftos, L. J., Nowlan, W. J., Clayton, E. W.
(2003). Ethics and Genetics. NEJM
349: 1870-1872
[Full Text]
Guttmacher, A. E., Collins, F. S.
(2003). Welcome to the Genomic Era. NEJM
349: 996-998
[Full Text]
Previous
